Status:
COMPLETED
New Protocol With Diluted Citrate in Continuous Techniques
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Acute Renal Failure
Dialysis; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators designed a monitoring and control table of a citrate treatment on a specific monitor. This is the Baxter "Prismaflex" monitor, with 8.2 software version. Dialysis bath liquids market...
Detailed Description
Study design: quasi-experimental design. two groups: 1. Usual protocol with Multifiltrate monitor and citrate (136 mmol/l) 2. Intervention group. New protocol with Prismaflex monitor and citrate (18 ...
Eligibility Criteria
Inclusion
- Adult patients (regardless of their underlying pathology), who develop acute renal failure, admitted to the ICU of St Pau with the medical team of Intensive Medicine, who require anticoagulation with citrate in continuous dialysis therapy and are treated with the Baxter monitor.
Exclusion
- parenteral nutrition
- pregnancy
- cardiac surgery
- coronary patients
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04062812
Start Date
August 1 2019
End Date
December 20 2021
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08041